R-ONE vascular surgical
Built by MicroPort MedBot (Group) · China
The R-ONE vascular surgical is a Surgical / Medical robot developed by MicroPort MedBot (Group) (China), launched 2014. Key specifications: procedures percutaneous coronary intervention (PCI), vascular intervention, imaging compat. compatible with mainstream cath lab imaging systems, fda year false, ce mark year true.
Robo Index
Weak evidence
5 of 10 signals present
Recomputed nightly from public data. Missing data is skipped, never zero-filled — and rankings are never for sale.
Weighted factors
average of the 5 scored · blanks don't count
Will it fit your job?
Tell us the job in plain words — we'll show how this robot measures up, line by line.
Tell us what your job needs — payload, budget, region, must-have certifications — and we'll show how R-ONE vascular surgical measures up, requirement by requirement. The Robo Index (trust) above is shown for every buyer, regardless.
Overview
The R-ONE Vascular Intervention Robot is the world's first dual-finger grasp mimic vascular intervention robot, designed for percutaneous coronary intervention (PCI). It reproduces manual operation with 0-360 degree rotating and continuous movement, millimeter stepping for precision, and one-key locking/unlocking. It received China approval in February 2024, previously CE-marked, and is the only commercialized CE-marked vascular robotic platform. In Chinese clinical trials it achieved 100% clinical and technological success in challenging cases including large angle twisted vessels, diffuse long lesions, calcified lesions, and sub-total occlusions. Compatible with mainstream interventional devices and cath labs. 5G remote PCI capability demonstrated over 2800 km in July 2023.
Flagship features
- World's first dual-finger grasp mimic technology for vascular intervention
- 0-360 degree continuous rotation mimicking hand gestures
- Millimeter stepping for precise device positioning
- One-key locking/unlocking for secured lesion access
- 100% clinical and technological success rate in Chinese clinical trials
- Only commercialized CE-marked vascular robotic platform
Buyer decision signals
Deployments
National Institute of Cardiovascular Diseases (NICVD)
Viability
DFVision imaging system received CE mark
Specifications
Category: Surgical / Medical- Procedures
- percutaneous coronary intervention (PCI), vascular intervention
- Imaging compat.
- compatible with mainstream cath lab imaging systems
- FDA year
- false
- CE mark year
- true
Company profile
- Founded
- 2015
Detailed specifications
Other3
- Sub Category
- vascular_intervention
- Company Country
- CN
- Additional Information
- - World's first dual-finger grasp mimic technology for vascular intervention - 0-360 degree continuous rotation mimicking hand gestures - Millimeter stepping for precise device positioning - One-key locking/unlocking for secured lesion access - 100% clinical and technological success rate in Chinese clinical trials - Only commercialized CE-marked vascular robotic platform - Compatible with mainstream interventional devices and cath labs - Active development of 5G remote robotic PCI technology (demonstrated over 2800 km) - Parent company MicroPort MedBot (HKEX: 02252) is an associated company of MicroPort Scientific Corporation (HKEX: 00853) - Covers seven surgical robot subsectors: endoscopy, orthopedics, vascular intervention, natural orifice surgery, percutaneous puncture, medical aesthetics - Uses advanced robotics, control algorithms, electrical engineering, image-based navigation and precision imaging
Who runs it· deployment evidence
1 on record · none maker-verified yet. Each links to its source — open it and judge.
- National Institute of Cardiovascular Diseases (NICVD)· Bangladeshsource ↗
Where to buy
Get a price or reach an authorized seller — pick your region, then request a quote.
No authorized seller is listed for this robot yet — request a quote below and we’ll connect you with MicroPort MedBot (Group) Co., Ltd. or an authorized seller.
Request a quote — goes straight to MicroPort MedBot (Group) Co., Ltd..
Every authorized seller serving your region is shown equally — placement is never sold, and this data never affects a robot’s score. A seller’s absence here doesn’t mean they aren’t authorized.
Company milestones
- Nov 2025MilestoneDFVision imaging system received CE mark
- Oct 2025Milestone100 global commercial orders reached
- May 2025LaunchNMPA approval for commercial telesurgery
- Mar 2024DeploymentR-ONE performed complex vascular procedures at NICVD
- Feb 2024LaunchR-ONE received approval in China
- Dec 2023LaunchR-ONE approved by NMPA for market launch
- Jul 2023DeploymentFirst 5G ultra-remote robotic PCI with R-ONE
- Nov 2021MilestoneHKEX listing
Compare with peers
More by MicroPort MedBot (Group)
Frequently asked questions
- Who makes the R-ONE vascular surgical?
- The R-ONE vascular surgical is developed by MicroPort MedBot (Group), based in China.
- What type of robot is the R-ONE vascular surgical?
- The R-ONE vascular surgical is a Surgical / Medical robot made by MicroPort MedBot (Group).
- How much does the R-ONE vascular surgical cost?
- Pricing for the R-ONE vascular surgical is not publicly listed — contact MicroPort MedBot (Group) for a quote.
- When was the R-ONE vascular surgical launched?
- The R-ONE vascular surgical was launched in 2014.
- What are the key specifications of the R-ONE vascular surgical?
- Key specifications of the R-ONE vascular surgical: procedures percutaneous coronary intervention (PCI), vascular intervention, imaging compat. compatible with mainstream cath lab imaging systems, fda year false, ce mark year true.
Reviews for R-ONE vascular surgical
Loading reviews…
